Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 4.070
-0.050 (-1.21%)
Feb 3, 2026, 3:04 PM CST
Dezhan Healthcare Company Revenue
Dezhan Healthcare Company had revenue of 111.14M CNY in the quarter ending September 30, 2025, with 4.70% growth. This brings the company's revenue in the last twelve months to 389.51M, down -24.72% year-over-year. In the year 2024, Dezhan Healthcare Company had annual revenue of 466.49M, down -6.34%.
Revenue (ttm)
389.51M
Revenue Growth
-24.72%
P/S Ratio
21.91
Revenue / Employee
369.56K
Employees
1,054
Market Cap
8.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 466.49M | -31.60M | -6.34% |
| Dec 31, 2023 | 498.09M | -72.77M | -12.75% |
| Jan 1, 2023 | 570.86M | -163.62M | -22.28% |
| Jan 1, 2022 | 734.48M | -228.39M | -23.72% |
| Dec 31, 2020 | 962.87M | -812.10M | -45.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harbin Pharmaceutical Group | 15.94B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.04B |
| KPC Pharmaceuticals,Inc. | 7.35B |
| Zhejiang Xianju Pharmaceutical | 3.59B |
| Tianjin Ringpu Bio-Technology | 3.37B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| PharmaBlock Sciences (Nanjing) | 1.98B |